BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32890459)

  • 1. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
    Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
    Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies.
    Tu J; Huo Z; Yu Y; Zhu D; Xu A; Huang MF; Hu R; Wang R; Gingold JA; Chen YH; Tsai KL; Forcioli-Conti NR; Huang SXL; Webb TR; Su J; Bazer DA; Jia P; Yustein JT; Wang LL; Hung MC; Zhao Z; Huff CD; Shen J; Zhao R; Lee DF
    Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2117857119. PubMed ID: 35412907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.
    Wang JY; Wu PK; Chen PC; Lee CW; Chen WM; Hung SC
    Stem Cells Transl Med; 2017 Feb; 6(2):512-526. PubMed ID: 28191765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteosarcoma without prior retinoblastoma related to RB1 low-penetrance germline pathogenic variants: A novel type of RB1-related hereditary predisposition syndrome?
    Imbert-Bouteille M; Gauthier-Villars M; Leroux D; Meunier I; Aerts I; Lumbroso-Le Rouic L; Lejeune S; Delnatte C; Abadie C; Pujol P; Houdayer C; Corsini C
    Mol Genet Genomic Med; 2019 Dec; 7(12):e913. PubMed ID: 31568710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of germline
    Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
    Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer molecular analysis of the RB tumor suppressor pathway.
    Knudsen ES; Nambiar R; Rosario SR; Smiraglia DJ; Goodrich DW; Witkiewicz AK
    Commun Biol; 2020 Apr; 3(1):158. PubMed ID: 32242058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
    Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
    Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an induced pluripotent stem cell line (LVPEIi002-A) with heterozygous RB1 mutation using peri-orbital fat derived mesenchymal cells of a patient with inherited retinoblastoma.
    Agrawal T; Maddileti S; Verma A; Kaliki S; Mariappan I
    Stem Cell Res; 2024 Apr; 76():103329. PubMed ID: 38335663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
    Deng X; Iwagawa T; Fukushima M; Watanabe S
    Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous identification of clinically relevant
    Xu L; Shen L; Polski A; Prabakar RK; Shah R; Jubran R; Kim JW; Biegel J; Kuhn P; Cobrinik D; Hicks J; Gai X; Berry JL
    Ophthalmic Genet; 2020 Dec; 41(6):526-532. PubMed ID: 32799607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Protein Tyrosine Phosphatase RptpĪ¶ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.
    Baldauf C; Jeschke A; Kanbach V; Catala-Lehnen P; Baumhoer D; Gerull H; Buhs S; Amling M; Nollau P; Harroch S; Schinke T
    PLoS One; 2015; 10(9):e0137745. PubMed ID: 26360410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel insights into RB1 mutation.
    Yao Y; Gu X; Xu X; Ge S; Jia R
    Cancer Lett; 2022 Oct; 547():215870. PubMed ID: 35964818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
    Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
    Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of new candidate genes in retinoblastoma using the TruSight One "clinical exome" gene panel.
    Akdeniz D; Tuncer SB; Kebudi R; Celik B; Kuru G; Kilic S; Sukruoglu Erdogan O; Avsar M; Buyukkapu Bay S; Tuncer S; Yazici H
    Mol Genet Genomic Med; 2019 Aug; 7(8):e785. PubMed ID: 31207142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
    Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
    Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing-Opening Pathways to New Therapeutic Strategies?
    Collin J; Queen R; Zerti D; Steel DH; Bowen C; Parulekar M; Lako M
    Invest Ophthalmol Vis Sci; 2021 May; 62(6):18. PubMed ID: 34003213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma.
    Zoumpoulidou G; Alvarez-Mendoza C; Mancusi C; Ahmed RM; Denman M; Steele CD; Tarabichi M; Roy E; Davies LR; Manji J; Cristalli C; Scotlandi K; Pillay N; Strauss SJ; Mittnacht S
    Nat Commun; 2021 Dec; 12(1):7064. PubMed ID: 34862364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUNX2 expression in developing human bones and various bone tumors.
    Sugawara M; Kato N; Tsuchiya T; Motoyama T
    Pathol Int; 2011 Oct; 61(10):565-71. PubMed ID: 21951664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis.
    Shimizu T; Ishikawa T; Sugihara E; Kuninaka S; Miyamoto T; Mabuchi Y; Matsuzaki Y; Tsunoda T; Miya F; Morioka H; Nakayama R; Kobayashi E; Toyama Y; Kawai A; Ichikawa H; Hasegawa T; Okada S; Ito T; Ikeda Y; Suda T; Saya H
    Oncogene; 2010 Oct; 29(42):5687-99. PubMed ID: 20676132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoblastoma patient-derived stem cells-an in vivo model to study the role of RB1 in adipogenesis.
    Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
    Histochem Cell Biol; 2022 Aug; 158(2):181-192. PubMed ID: 35445864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.